• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Corcept Therapeutics

Corcept Therapeutics

Corcept Therapeutics Inc CORT

Last Price$2.96Day Change (%)-1.66%
Open Price$3.00Day Change ($)-0.05
Day Range2.92–3.0852-Week Range1.60–4.49

As of Wed 10/22/2014 03:59 PM EST | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  1. EMAS AMC Finalises Triple Contract Signings With Noble Energy for Subsea Tie-Back Projects in the US Gulf of Mexico

    EMAS AMC Finalises Triple Contract Signings With Noble Energy for Subsea Tie-Back Projects in the US Gulf of Mexico

  2. Cortendo Appoints Robert Lutz as Chief Business Officer

    Cortendo Appoints Robert Lutz as Chief Business Officer

  3. Cortendo AB to Present at the 13th Annual BIO Investor Forum in San Francisco October 7, 2014

    Cortendo AB to Present at the 13th Annual BIO Investor Forum in San Francisco October 7, 2014

  4. A Young Power Couple's Kickstart Portfolio

    With "massive" student debt loads receding in the rearview mirror, a young professional couple fires up their investment plan.

  5. Berkshire's Second-Quarter Results on Target

    Noninsurance operations continue to be a source of stability, while its insurance business overall may see more meager results during the next couple of years.

  6. Berkshire Starts Out 2014 on a Weaker Note

    Just about every segment at Berkshire was dealing with elevated costs during the first quarter.

  7. How We Value Berkshire Hathaway

    Alternative methods have some use, but we think discounted cash flow is the most fundamentally sound way to value the conglomerate, as we discuss in the final installment of our 5-part series.

  8. Why Berkshire's Moat Isn't Going Away Anytime Soon

    Morningstar's Gregg Warren says Berkshire's sterling balance sheet, strong business, and unique structure will sustain the firm's competitive standing--even without Buffett.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.